The FDA authorized a second dose of the upgraded COVID-19 booster manufactured by Pfizer and Moderna, for individuals over 65 and with weakened immune systems.
Sen. Rand Paul, R-Ky., discusses the origins of COVID, telling 'America Reports' there is a 'mountain of evidence' the virus came from a lab and no proof it came from animals.announced on Tuesday that older individuals and those with weakened immune systems are eligible for another dose of the updated COVID-19 booster.
But people over the age of 65, or individuals with weakened immune systems, who received a single dose of theThose over the age of 65, the FDA said, must wait at least four months from when they received the most recent booster, while those who are immunocompromised only must wait two months.Immunocompromised individuals can get additional doses at the discretion and interval of their healthcare provider, for the most part.
Most people who are unvaccinated, the FDA said, can get a single dose of the latest bivalent COVID shot, which contains two strains of the virus, rather than multiple doses of the vaccine as originally administered. Last month, the FDA authorized a single booster dose of the Pfizer-BioNTech COVID-19 vaccine for children six months old through four years of age, though to get it, they were required to have completed their three-dose primary vaccination series within two months of getting the booster.Children in that age range who only received the first two doses of Pfizer COVID-19 vaccine were not eligible for the booster.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA simplifies COVID vaccine schedules, withdraws authorization for older COVID-19 vaccines targeting virus' original strainThe FDA is authorizing a second omicron-targeted bivalent COVID-19 booster vaccine for people over 65 or who are immunocompromised, the agency announces.
Read more »
FDA okays second omicron booster for people at high risk from covidBreaking news: FDA clears a second omicron-targeting booster shot for people who are at high risk from the coronavirus
Read more »
FDA authorizes second bivalent COVID booster for older adultsThe U.S. Food and Drug Administration on Tuesday authorized a second dose of Omicron-targeting COVID-19 vaccines for older adults as well as those with a weak immune system.
Read more »
FDA clears second bivalent COVID boosters for some AmericansSome Americans will soon be able to get another shot of the bivalent COVID-19 vaccines, the FDA authorized Tuesday, including seniors ages 65 and older and people with compromised immune systems.
Read more »
FDA authorizes 2nd dose of updated Covid booster for older adultsPeople 65 and up can get a second dose of the updated booster at least four months after their last dose.
Read more »
FDA authorizes additional omicron Covid shots for seniors and people with weak immune systemsAlthough the burden of the pandemic has eased substantially, the CDC says Covid continues to kill more than 1,300 people per week.
Read more »